Lee JTL, et al. - The researchers sought to estimate the effectiveness of adalimumab in cases having active and inactive non-infectious uveitis. The corticosteroid burden appeared to be reduced by adalimumab in active and inactive non-infectious uveitis. The long-term success of this treatment could be identified by the inflammatory activity at the time of commencement of adalimumab.